ALB and chronic myelogenous leukemia, BCR-ABL1 positive: The most similar approach to this phenomenon is the study of Lavallade et al. [14], which showed that TKIs against BCR-ALB translocation affect B-cell immune responses in chronic myeloid leukemia.